The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease
Open accessAbstract
Background— Fibroblast growth factor 23 (FGF-23) is a phosphorus-regulating hormone. In chronic kidney disease (CKD), circulating FGF-23 levels are markedly elevated and independently associated with mortality. Left ventricular hypertrophy and coronary artery calcification are potent risk factors for mortality in CKD, and FGFs have been implicated in the pathogenesis of both myocardial hypertrophy and atherosclerosis. We conducted a cross-sectional study to test the hypothesis that elevated FGF-23 concentrations are associated with left ventricular hypertrophy and coronary artery calcification in patients with CKD. Methods and Results— In this study, 162 subjects with CKD underwent echocardiograms and computed tomography scans to assess left ventricular mass index and coronary artery calcification; echocardiograms also were obtained in 58 subjects without CKD. In multivariable-adjusted regression analyses in the overall sample, increased log FGF-23 concentrations were independently associated with increased left ventricular mass index (5% increase per 1-SD increase in log FGF-23; P =0.01) and risk of left ventricular hypertrophy (odds ratio per 1-SD increase in log FGF-23, 2.1; 95% confidence interval, 1.03 to 4.2). These associations strengthened in analyses restricted to the CKD subjects (11% increase in left ventricular mass index per 1-SD increase in log FGF-23; P =0.01; odds ratio of left ventricular hypertrophy per 1-SD increase in log FGF-23, 2.3; 95% confidence interval, 1.2 to 4.2). Although the highest tertile of FGF-23 was associated with a 2.4-fold increased risk of coronary artery calcification ≥100 versus <100 U compared with the lowest tertile (95% confidence interval, 1.1 to 5.5), the association was no longer significant after multivariable adjustment. Conclusions— FGF-23 is independently associated with left ventricular mass index and left ventricular hypertrophy in patients with CKD. Whether increased FGF-23 is a marker or a potential mechanism of myocardial hypertrophy in CKD requires further study.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Levey, A. S., Bosch, J. P., Lewis, J. B., Greene, T., Rogers, N., Roth, D., & for the Modification of Diet in Renal Disease Study Group* (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-6-199903160-00002 · Cited by 15,079
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
Go, A. S., Chertow, G. M., Fan, D., McCulloch, C. E., & Hsu, C.-Y. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041031 · Cited by 11,369
Lang, R. M., Bierig, M., Devereux, R. B., Flachskampf, F. A., Foster, E., Pellikka, P. A., Picard, M. H., Roman, M. J., Seward, J., Shanewise, J. S., et al. (2005) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2005.10.005 · Cited by 11,318
Quantification of coronary artery calcium using ultrafast computed tomography
Agatston, A. S., Janowitz, W. R., Hildner, F. J., Zusmer, N. R., Viamonte, M., & Detrano, R. (1990) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(90)90282-t · Cited by 7,786
Prevalence of Chronic Kidney Disease in the United States
Coresh, J., Selvin, E., Stevens, L. A., Manzi, J., Kusek, J. W., Eggers, P., Van Lente, F., & Levey, A. S. (2007) · JAMA · doi:10.1001/jama.298.17.2038 · Cited by 4,895
Sarnak, M. J., Levey, A. S., Schoolwerth, A. C., Coresh, J., Culleton, B., Hamm, L. L., McCullough, P. A., Kasiske, B. L., Kelepouris, E., Klag, M. J., et al. (2003) · Circulation · doi:10.1161/01.cir.0000095676.90936.80 · Cited by 3,768
Mineral Metabolism, Mortality, and Morbidity in Maintenance Hemodialysis
Block, G. A., Klassen, P. S., Lazarus, J. M., Ofsthun, N., Lowrie, E. G., & Chertow, G. M. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000133041.27682.a2 · Cited by 2,687
Greenland, P. (2004) · JAMA · doi:10.1001/jama.291.2.210 · Cited by 1,829
Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis
Gutiérrez, O. M., Mannstadt, M., Isakova, T., Rauh-Hain, J. A., Tamez, H., Shah, A., Smith, K., Lee, H., Thadhani, R., Jüppner, H., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706130 · Cited by 1,727
Self-citationPatterns of left ventricular hypertrophy and geometric remodeling in essential hypertension
Ganau, A., Devereux, R. B., Roman, M. J., de Simone, G., Pickering, T. G., Saba, P. S., Vargiu, P., Simongini, I., & Laragh, J. H. (1992) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(92)90617-v · Cited by 1,605
Serum Phosphate Levels and Mortality Risk among People with Chronic Kidney Disease
Kestenbaum, B., Sampson, J. N., Rudser, K. D., Patterson, D. J., Seliger, S. L., Young, B., Sherrard, D. J., & Andress, D. L. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004070602 · Cited by 1,226
Gutierrez, O., Isakova, T., Rhee, E., Shah, A., Holmes, J., Collerone, G., Ju[Combining Diaeresis]ppner, H., & Wolf, M. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005010052 · Cited by 921
Self-citationRelation Between Serum Phosphate Level and Cardiovascular Event Rate in People With Coronary Disease
Tonelli, M., Sacks, F., Pfeffer, M., Gao, Z., & Curhan, G. (2005) · Circulation · doi:10.1161/circulationaha.105.553198 · Cited by 885
Block, G. A., Raggi, P., Bellasi, A., Kooienga, L., & Spiegel, D. M. (2007) · Kidney International · doi:10.1038/sj.ki.5002059 · Cited by 796
Impact of left ventricular hypertrophy on survival in end-stage renal disease
Silberberg, J. S., Barre, P. E., Prichard, S. S., & Sniderman, A. D. (1989) · Kidney International · doi:10.1038/ki.1989.192 · Cited by 784
Levin, A., Singer, J., Thompson, C. R., Ross, H., & Lewis, M. (1996) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(96)90357-1 · Cited by 709
Fliser, D., Kollerits, B., Neyer, U., Ankerst, D. P., Lhotta, K., Lingenhel, A., Ritz, E., & Kronenberg, F. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006080936 · Cited by 699
Xiang, W., Kong, J., Chen, S., Cao, L.-P., Qiao, G., Zheng, W., Liu, W., Li, X., Gardner, D. G., & Li, Y. C. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00224.2004 · Cited by 570
Coronary Calcification Improves Cardiovascular Risk Prediction in the Elderly
Vliegenthart, R., Oudkerk, M., Hofman, A., Oei, H.-H. S., van Dijck, W., van Rooij, F. J. A., & Witteman, J. C. M. (2005) · Circulation · doi:10.1161/circulationaha.104.488916 · Cited by 540
Ferrari, S. L., Bonjour, J.-P., & Rizzoli, R. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1039 · Cited by 518
How Fibroblast Growth Factor 23 Works
Liu, S., & Quarles, L. D. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007010068 · Cited by 408
Left Ventricular Hypertrophy in the Renal Patient
MIDDLETON, R. J., PARFREY, P. S., & FOLEY, R. N. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1251079 · Cited by 294
Prognostic Impact of the Indexation of Left Ventricular Mass in Patients Undergoing Dialysis
Zoccali, C., Benedetto, F. A., Mallamaci, F., Tripepi, G., Giacone, G., Cataliotti, A., Seminara, G., Stancanelli, B., & Malatino, L. S. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v12122768 · Cited by 292
Hughes, S. E. (1997) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215549704500710 · Cited by 280
Association between Chronic Kidney Disease and Coronary Artery Calcification: The Dallas Heart Study
Kramer, H., Toto, R., Peshock, R., Cooper, R., & Victor, R. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004070610 · Cited by 272
Ayus, J. C., Mizani, M. R., Achinger, S. G., Thadhani, R., Go, A. S., & Lee, S. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005040392 · Cited by 265
Improved electrocardiographic diagnosis of left ventricular hypertrophy
Schillaci, G., Verdecchia, P., Borgioni, C., Ciucci, A., Guerrieri, M., Zampi, I., Battistelli, M., Bartoccini, C., & Porcellati, C. (1994) · The American Journal of Cardiology · doi:10.1016/0002-9149(94)90316-6 · Cited by 248
The Mechanism of Phosphorus as a Cardiovascular Risk Factor in CKD
Mathew, S., Tustison, K. S., Sugatani, T., Chaudhary, L. R., Rifas, L., & Hruska, K. A. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007070760 · Cited by 237
Brunner-La Rocca, H. P., Kaye, D. M., Woods, R. L., Hastings, J., & Esler, M. D. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01172-x · Cited by 235
Analysis of the Biochemical Mechanisms for the Endocrine Actions of Fibroblast Growth Factor-23
Yu, X., Ibrahimi, O. A., Goetz, R., Zhang, F., Davis, S. I., Garringer, H. J., Linhardt, R. J., Ornitz, D. M., Mohammadi, M., & White, K. E. (2005) · Endocrinology · doi:10.1210/en.2005-0670 · Cited by 213
Fibroblast Growth Factor-2 Regulates Myocardial Infarct Repair
Virag, J. A. I., Rolle, M. L., Reece, J., Hardouin, S., Feigl, E. O., & Murry, C. E. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070003 · Cited by 170
Fibroblast growth factor-2 mediates pressure-induced hypertrophic response
Schultz, J. E. J., Witt, S. A., Nieman, M. L., Reiser, P. J., Engle, S. J., Zhou, M., Pawlowski, S. A., Lorenz, J. N., Kimball, T. R., & Doetschman, T. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7315 · Cited by 164
Chronic Kidney Disease Predicts Cardiovascular Disease
Hostetter, T. H. (2004) · New England Journal of Medicine · doi:10.1056/nejme048211 · Cited by 155
Myocardial interstitial fibrosis in experimental uremia—Implications for cardiac compliance
Mall, G., Rambausek, M., Neumeister, A., Kollmar, S., Vetterlein, F., & Ritz, E. (1988) · Kidney International · doi:10.1038/ki.1988.71 · Cited by 152
Koiwa, F., Kazama, J. J., Tokumoto, A., Onoda, N., Kato, H., Okada, T., Nii‐Kono, T., Fukagawa, M., & Shigematsu, T. (2005) · Therapeutic Apheresis and Dialysis · doi:10.1111/j.1744-9987.2005.00293.x · Cited by 138
Roos, M., Lutz, J., Salmhofer, H., Luppa, P. B., Knauß, A., Braun, S., Martinof, S., Schömig, A., Heemann, U. W., Kastrati, A., et al. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03074.x · Cited by 94
Garland, J. S., Holden, R. M., Groome, P. A., Lam, M., Nolan, R. L., Morton, A. R., & Pickett, W. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.04.012 · Cited by 83
Verma, A., Anavekar, N. S., Meris, A., Thune, J. J., Arnold, J. M. O., Ghali, J. K., Velazquez, E. J., McMurray, J. J. V., Pfeffer, M. A., & Solomon, S. D. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.06.018 · Cited by 81
Trophic Effect of Human Pericardial Fluid on Adult Cardiac Myocytes
Corda, S., Mebazaa, A., Gandolfini, M.-P., Fitting, C., Marotte, F., Peynet, J., Charlemagne, D., Cavaillon, J., Payen, D. M., Rappaport, L., et al. (1997) · Circulation Research · doi:10.1161/01.res.81.5.679 · Cited by 80
Adult cardiomyocytes express functional high-affinity receptors for basic fibroblast growth factor
Liu, L., Pasumarthi, K. B. S., Padua, R. R., Massaeli, H., Fandrich, R. R., Pierce, G. N., Cattini, P. A., & Kardami, E. (1995) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1995.268.5.h1927 · Cited by 54
Damgaard, M., Goetze, J. P., Norsk, P., & Gadsbøll, N. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm396 · Cited by 32
The Long-Term Behavior and Predictors of Left Ventricular Hypertrophy in Hemodialysis Patients
Kutlay, S., Dinçer, İ., Şengül, Ş., Nergızoğlu, G., Duman, N., & Ertürk, Ş. (2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.12.029 · Cited by 31
Basic fibroblast growth factor induces myocardial hypertrophy following acute infarction in rats
Scheinowitz, M., Kotlyar, A., Zimand, S., Ohad, D. G., Leibovitz, I., Bloom, N., Goldberg, I., Nass, D., Engelberg, S., Savion, N., et al. (1998) · Experimental Physiology · doi:10.1113/expphysiol.1998.sp004140 · Cited by 28
Cited by
FGF23 induces left ventricular hypertrophy
Faul, C., Amaral, A. P., Oskouei, B., Hu, M.-C., Sloan, A., Isakova, T., Gutiérrez, O. M., Aguillon-Prada, R., Lincoln, J., Hare, J. M., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46122 · Cited by 2,027
Self-citationIsakova, T., on behalf of the Chronic Renal Insufficiency Cohort (CRIC) Study Group, Wahl, P., Vargas, G. S., Gutiérrez, O. M., Scialla, J., Xie, H., Appleby, D., Nessel, L., Bellovich, K., et al. (2011) · Kidney International · doi:10.1038/ki.2011.47 · Cited by 1,266
Self-citationIsakova, T. (2011) · JAMA · doi:10.1001/jama.2011.826 · Cited by 1,020
Self-citationRegulation and Function of the FGF23/Klotho Endocrine Pathways
Martin, A., David, V., & Quarles, L. D. (2012) · Physiological Reviews · doi:10.1152/physrev.00002.2011 · Cited by 594
Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy
Grabner, A., Amaral, A. P., Schramm, K., Singh, S., Sloan, A., Yanucil, C., Li, J., Shehadeh, L. A., Hare, J. M., David, V., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.09.002 · Cited by 541
Self-citation
Metadata
- Authors
- Gutiérrez, O. M., Januzzi, J. L., Isakova, T., Laliberte, K., Smith, K., Collerone, G., Sarwar, A., Hoffmann, U., Coglianese, E., Christenson, R., Wang, T. J., deFilippi, C., & Wolf, M.
- Venue
- Circulation
- Published
- 2009-05-19
- Volume
- 119
- Issue
- 19
- Pages
- 2545-2552
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2157448600
- Cited by
- 837
- References
- 43
- FWCI
- 37.93
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.